| Serial Number | 88111828 |
| Word Mark | ENOVANT |
| Filing Date | Tuesday, September 11, 2018 |
| Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
| Status Date | Wednesday, September 8, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 24, 2019 |
| Goods and Services | Computer software using artificial intelligence for providing, analyzing and generating reports; computer software for providing, analyzing and generating reports; computer software for data processing; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceutical and biomedical research and development, clinical and post-market trials, and the provision of medical and healthcare services; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information |
| Goods and Services | Business consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; professional business analysis and consultancy and statistical analysis in the fields of healthcare, biomedicine, pharmaceuticals, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare from an on-line database; providing commercial and business contact information within the scientific research and medical communities to achieve advances in the field of healthcare; business networking services within the scientific research and medical communities to achieve advances in the field of healthcare; compilation of data, analysis of business data and professional business analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare for business purposes; compilation of data, analysis of business data and professional business analysis for medical and healthcare for business purposes; providing reimbursement benchmarking information and other market intelligence to healthcare organizations; collecting and professional business analysis of claims data from healthcare organizations for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for business purposes |
| Goods and Services | Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; financial research related to financial instruments |
| Goods and Services | Scientific and technological services, namely, scientific research and analysis, and diagnostic services in the field of pharmaceuticals and biomedicine; industrial analysis and research services in the field of pharmaceuticals and biomedicine; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; conducting clinical trials and post-market trials; epidemiological research services, pharmacoepidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, and pharmacoepidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmacoepidemiological research, and clinical trial and post-market trial data via a computer database or the Internet; providing scientific research information in the fields of healthcare, biomedicine, pharmaceuticals, and clinical and post-market clinical trials; providing temporary use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; compiling data for research and analysis for medical science purposes in the field of healthcare, pharmaceuticals, biomedicine, clinical trials and post-market trials |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, September 8, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, September 8, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, September 8, 2021 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, September 8, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Roivant Sciences GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Roivant Sciences GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Wednesday, September 8, 2021 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION |
| Wednesday, September 8, 2021 | ABANDONMENT - AFTER INTER PARTES DECISION |
| Wednesday, September 8, 2021 | OPPOSITION TERMINATED NO. 999999 |
| Wednesday, September 8, 2021 | OPPOSITION DISMISSED NO. 999999 |
| Wednesday, January 22, 2020 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, January 22, 2020 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Tuesday, December 24, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 24, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 4, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, November 15, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, November 13, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 29, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, October 29, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 29, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 29, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 30, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 30, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 30, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, April 15, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 15, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 15, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 16, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 16, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 16, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 10, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, October 2, 2018 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Sunday, September 30, 2018 | ASSIGNED TO LIE |
| Thursday, September 20, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, September 18, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, September 14, 2018 | NEW APPLICATION ENTERED IN TRAM |